Aug 9 (Reuters) - Aralez Pharmaceuticals Inc:
* Aralez reports second quarter 2017 financial results
* Aralez Pharmaceuticals Inc - total revenues for 3 months ended June 30, 2017 were $27.6 million compared to $12.6 million for three months ended June 30, 2016
* Qtrly loss per share $0.42
* Aralez Pharmaceuticals Inc - as of June 30, 2017 company had cash and cash equivalents of approximately $55.8 million
* Aralez Pharmaceuticals Inc - company currently believes it has sufficient cash to fund operations for at least next 12 months Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.